Day: May 28, 2020

NORWALK, Conn., May 28, 2020 (GLOBE NEWSWIRE) — FactSet (NYSE:FDS | NASDAQ:FDS), a global provider of integrated financial information, analytical applications, and industry-leading services, today announced that it will release its financial and operating results for the third quarter fiscal 2020, ending May 31, on Thursday, June 25, 2020. FactSet will also host a conference call to discuss these results at 11:00 a.m. eastern time.The following information is provided for investors who would like to participate in the conference call and webcast:U.S. Participants:               833.726.6487International Participants:  830.213.7677Passcode:                          2889655Webcast:                            FactSet Investor RelationsAn archived webcast with the accompanying slides will be available at investor.factset.com for one...

HOLLYWOOD, Fla., May 28, 2020 (GLOBE NEWSWIRE) — NV5 Global, Inc. (the “Company” or “NV5”) (Nasdaq: NVEE), a provider of professional and technical engineering, geospatial, and consulting solutions, announced today that Quantum Spatial, Inc. (“Quantum Spatial”), an NV5 company, has been awarded two contracts totaling $3 million by NASA and the California Department of Water Resources (DWR) to provide remote sensing services in support of water conservation efforts in the Western United States.  Quantum Spatial was selected to evaluate high-accuracy lidar and hyperspectral imaging in Colorado and Idaho for the NASA SnowEx 2020 campaign, which is analyzing technologies for measuring snowpack and corresponding snow water equivalency (SWE) in a variety of ecosystems.  The SnowEx 2020 campaign is a research effort funded by the NASA...

SALT LAKE CITY, May 28, 2020 (GLOBE NEWSWIRE) — Nu-Med Plus, Inc. (OTCQB: NUMD), a medical device company which investigates and develops applications and devices for nitric oxide delivery in the medical field, today announced that the United States Patent and Trademark Office (“USPTO”) has allowed the issuance of a patent for a single-use or short-term use nitric oxide inhaler.This patent allowance will provide the Company the capability of providing individual nitric oxide treatment options in emergency situations, to be used in remote and rural areas that has the capability to rapidly deliver the prescribed dose of nitric oxide when serious and instantaneous use is needed.Typically, nitric oxide delivery devices are large, electronically complex devices that are used primarily in neonatal intensive care units.  The importance...

NEW YORK and BASEL, Switzerland, May 28, 2020 (GLOBE NEWSWIRE) — Axovant Gene Therapies, Ltd. (NASDAQ: AXGT), a clinical-stage company developing innovative gene therapies for neurological diseases, today announced that Parag Meswani, Pharm.D., SVP of Commercial Strategy and Operations, will present at the Jefferies Global Virtual Healthcare Conference.Presentation Details:A replay of the presentation will be available in the Events section of Axovant’s website at www.axovant.com for approximately 30 days following the conference.About Axovant Gene TherapiesAxovant Gene Therapies is a clinical-stage gene therapy company focused on developing a pipeline of innovative product candidates for debilitating neurodegenerative diseases. Our current pipeline of gene therapy candidates targets GM1 gangliosidosis, GM2 gangliosidosis (including...

Montreal, Québec, May 28, 2020 (GLOBE NEWSWIRE) — Maya Gold & Silver Inc. (“Maya” or the “Company”) (TSX: MYA) is pleased to announce that for the current year, it has changed its format for the upcoming annual meeting of shareholders (“AGM”) to be held on Friday, June 19, 2020 at 10:00 a.m. (Eastern Time) to an online virtual only meeting. Under this format, shareholders may not physically attend the meeting in person but are welcome to attend and participate in the meeting online via live audio webcast. This change of format is in response to the current COVID-19 pandemic and more particularly in regards to the restrictions on mass gatherings implemented by the Government of Quebec. The decision to move to a virtual-only meeting reflects our commitment to protecting the health and safety of our shareholders, directors,...

SOUTHBOROUGH, Mass., May 28, 2020 (GLOBE NEWSWIRE) — Virtusa Corporation (NASDAQ GS: VRTU), a global provider of digital strategy, digital engineering, and IT services and solutions that help Global 2000 clients accelerate transformation through innovation engineering, today announced its new Digital Transformation Studio (DTS), a proprietary platform and approach designed to increase the delivery speed and dramatically reduce the costs of business critical digital transformation projects. According to a past study by McKinsey, 84% of respondents say their organizations’ digital transformations have failed to improve performance or to sustain the transformational changes in the long term. To better understand causality, Virtusa led a multi-year research project to gain deeper insights into the anatomy of successful digital transformation...

Municipality Finance PlcStock exchange release28 May 2020 at 3:00 pm (EET)Municipality Finance issues EUR 15 million notes under MTN programmeMunicipality Finance Plc issues EUR 15 million notes on 2 June 2020. The maturity of the notes is 10 years and the maturity date is 2 June 2030. MuniFin has the right but no obligation to redeem the notes early on the call date 2 June 2022. The notes bear interest at fixed rate of 0.21 % per annum.The notes are issued under MuniFin’s 40 billion programme for the issuance of debt instruments. The offering circular is available in English on the company’s website at www.munifin.fi/investor-relations.MuniFin has applied for the notes to be admitted to trading on the Helsinki Stock Exchange maintained by Nasdaq Helsinki. The public trading is expected to commence on 2 June 2020.Commerzbank AG...

Kuntarahoitus OyjPörssitiedote28.5.2020 klo 15.00Kuntarahoitus laskee liikkeeseen 15 miljoonan euron joukkovelkakirjalainan osana joukkovelkakirjalainaohjelmaaKuntarahoitus Oyj laskee liikkeeseen 15 miljoonan euron joukkovelkakirjalainan 2.6.2020. Lainan maturiteetti on 10 vuotta ja eräpäivä on 2.6.2030. Kuntarahoituksella on oikeus, mutta ei velvollisuutta eräännyttää joukkovelkakirjalaina ennenaikaisesti takaisinmaksettavaksi 2.6.2022. Lainalle maksetaan vuosittaista korkoa 0,21 %.Lainan liikkeeseenlasku tapahtuu yhtiön 40 miljardin euron joukkovelkakirjalainaohjelman alla. Ohjelmaa koskeva esite on saatavissa englanninkielisenä yhtiön verkkosivuilta osoitteesta www.munifin.fi/investor-relations.Kuntarahoitus on hakenut joukkovelkakirjalainan ottamista julkisen kaupankäynnin kohteeksi Nasdaq Helsinki Oy:n pörssilistalle. Julkisen kaupankäynnin...

AB201 (rNAPc2) is being developed as a potential treatment for COVID Associated Coagulopathy, a condition characterized by abnormal blood clotting in patients with COVID-19Previous safety data in more than 700 patients through Phase 2 may enable more rapid developmentARCA anticipates filing an IND in the third quarter of 2020 and initiating late-stage clinical testing in the second half of this yearPrior rNAPc2 results treating Ebola and Marburg viral infections in non-human primate trials support development as treatment for RNA virus associated diseaseAB201 (rNAPc2) is a potent inhibitor of tissue factor, a key driver of the viral infection process and associated inflammatory response, including virus-associated coagulopathyWESTMINSTER, Colo., May 28, 2020 (GLOBE NEWSWIRE) — ARCA biopharma, Inc. (Nasdaq: ABIO) today announced...